These includelncRNAs RP11-77G23.5 and PHEX-AS1 or miR-21, mir-378, miR-139, and mir-200 inlung-cancer-patient exosomes; miR-4732-5p in ovarian cancer; mir-375, miR-501-3p,mir-574-3p, and prostate-specific antigen mRNA in prostate cancer; mir-10b inpancreatic cancer; miR-375, miR-200c, and miR-222 in breast cancer exosomes;miR-15b-3p and lncRNA HOTTIP in gastric cancer; and miR-92b, miR-21, or a separatestudy looking at a panel of 10 miRNA markers in hepatocellular carcinoma (133-145). This evidence concerns the gene KLK3 and ovarian cancer.